| Watchers | 648 |
| 52-Wk Low | $4.60 |
| 52-Wk High | $20.90 |
| Market Cap | $756.36M |
| Volume | 150,363.00 |
| 52-Wk High | $20.90 |
| 52-Wk Low | $4.60 |
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Y-Mabs Therapeutics Inc market cap is $756.36M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Y-Mabs Therapeutics Inc 52 week high is $20.90 as of May 07, 2024.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Y-Mabs Therapeutics Inc 52 week low is $4.60 as of May 07, 2024.
Y-Mabs Therapeutics Inc stock price today is $17.22.
Y-Mabs Therapeutics Inc stock price yesterday was $17.24.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Y-Mabs Therapeutics Inc’s P/E ratio is -35.12.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Y-Mabs Therapeutics Inc P/B ratio is 7.4556.
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Y-Mabs Therapeutics Inc's EBITDA is -8.84.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Y-Mabs Therapeutics Inc 50-day moving average is $15.73.
Y-Mabs Therapeutics Inc has 100 employees.